Cardiovascular

Latest News

Heart examination | Image credit: Ngampol - stock.adobe.com

Elevated Stress Hyperglycemia Ratio Linked to Higher All-Cause Mortality After Cardiovascular Events

By Pearl Steinzor

November 20th 2024

Evidence highlights the predictive value of the stress hyperglycemia ratio for mortality risk in patients with acute myocardial infarction, ischemic stroke, and acute heart failure.

Smoking health risk | Image credit: sorapop - stock.adobe.com

How Smoking Cessation Affects Cardiovascular Disease Risk Over Time

By Pearl Steinzor

November 15th 2024

Stressed female employee | Image Credit: Charlie's - stock.adobe.com

Work-Related Stress Linked to Poor Cardiovascular Health

By Brooke McCormick

November 6th 2024

Doctor holding heart_Pana Studio - stock.adobe.com.jpeg

Evaluating the American Heart Association’s PREVENT Equations: Enhancing CVD Risk Prediction

By Pearl Steinzor

October 24th 2024

Viet Le, PA-C, Intermountain Health

Fostering Interdisciplinary Communication: How Cardio-Renal-Metabolic Care Models Optimize Care Delivery

October 19th 2024

Advancements in Population Health Strategies for Cardiovascular Risk Management

Experts discuss how lipoproteins drive atherosclerotic heart disease, review the different guidelines and recommendations on Lp(a) testing, and insights from clinical trials.

Hands holding a heart with a heartbeat on it and the words AJMC Insights

Continuing Medical Education

November 21st 2024

Advances and Best Practices for Managed Care Pharmacists in the Treatment of Heart Failure with Preserved Ejection Fraction

1.0 Credits / Cardiology

November 21st 2024

Exploring Transthyretin-Mediated Amyloidosis and Its Phenotypes: A Comprehensive Approach to Patient Treatment

1.5 Credits / Cardiology, Neurology, Rare Diseases

November 21st 2024

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology

More News

December 27th 2018

For Payers, Cost Is the Downside of Continuing Cardiovascular Outcomes Trials in Current Form

Kenneth Snow, MD, MBA

A perspective on the current FDA guidance for diabetes therapies.

What We're Reading: Long-Acting Contraceptives; Heart Surgery and Opioids; Undocumented and Seeking Care

December 27th 2018

What We're Reading: Long-Acting Contraceptives; Heart Surgery and Opioids; Undocumented and Seeking Care

Of US women between the ages of 15 and 49, 64.9% use some form of contraception, and the use of long-acting reversible contraceptives is increasing; people with prolonged opioid use have an increased risk for cardiovascular problems, but they are also more likely to develop major surgery complications; there are an estimated 11 million undocumented immigrants in the United States, and they struggle to receive basic medical care.

Duke Study to Examine How Diabetes, Cardiovascular Guidelines Get Into Clinical Practice

December 22nd 2018

Duke Study to Examine How Diabetes, Cardiovascular Guidelines Get Into Clinical Practice

The COORDINATE-Diabetes seeks to explore what happens between development of clinical guidelines and their translation into clinical practice.

December 22nd 2018

Clinical Evidence for and Cost-Effectiveness of Advanced Cellular Tissue Products for the Treatment of Diabetic Foot Ulcers

Robert S. Kirsner, MD, PhD

An estimated 30 million Americans are living with diabetes. Additionally, 84 million have prediabetes, a condition that will result in type 2 diabetes within 5 years if not properly treated. Long regarded as one of the most prevalent chronic diseases in United States, diabetes is also a leading cause of disability and the seventh-leading cause of death. Less discussed is one of the most common complications of diabetes: diabetic foot ulcers. If not properly treated with standard and adjunctive care, these chronic wounds can lead to permanent disability and premature death.

ADA Embraces CV Risk Calculator, Calls for Using GLP-1s Before Insulin in Type 2 Diabetes

December 18th 2018

ADA Embraces CV Risk Calculator, Calls for Using GLP-1s Before Insulin in Type 2 Diabetes

The 2019 Standards of Care reflect an ongoing collaboration between the American Diabetes Association and the American College of Cardiology.

The Most-Read News Stories of 2018

December 17th 2018

The Most-Read News Stories of 2018

Allison Inserro

Two of The American Journal of Managed Care®'s top 5 most-read news stories were themselves top-5 roundups of hot topics in healthcare this year. The list was rounded out by cardiovascular, diabetes, and cancer news.

Cardiologists See More Direct Oral Anticoagulants, Value Discussion of PCSK9s, and Technology in 2019

December 13th 2018

Cardiologists See More Direct Oral Anticoagulants, Value Discussion of PCSK9s, and Technology in 2019

A forecast from the American College of Cardiology covers trends from therapy to technology to value-based care.

Studies Show Medicaid Expansion Is Improving Health, While Jury Still Out on Chronic Disease

December 8th 2018

Studies Show Medicaid Expansion Is Improving Health, While Jury Still Out on Chronic Disease

A batch of studies appearing in recent months have linked Medicaid expansion with lower death rates in renal failure, more efforts to quit smoking, and earlier detection of cancer. There are mixed outcomes in chronic disease, but an important clinical trial in Oregon shows that over the long haul, Medicaid expansion makes a difference.

New Study Adds to Debate Over Statin Use to Prevent CVD

December 6th 2018

New Study Adds to Debate Over Statin Use to Prevent CVD

The authors say while guidelines look at the benefits of statins to prevent cardiovascular disease (CVD), they do not adequately assess the harms. The new model takes this into account.

A Little Weight Training Can Do a Lot to Cut Cardiovascular Risk, Study Finds

December 1st 2018

A Little Weight Training Can Do a Lot to Cut Cardiovascular Risk, Study Finds

Researchers described the study as one of the first to examine how strength training can reduce the risk of cardiovascular disease, separate from the effects of aerobic activity like running or long walks

November 30th 2018

CDC Data: Life Expectancy Decreases as Deaths From Suicide, Drug Overdose Increase

Laura Joszt, MA

New reports from the CDC have highlighted troubling increasing trends in suicides and drug overdose rates as life expectancy in the United States declined.

November 29th 2018

Increasing Awareness This National Diabetes Month Can Save Limbs and Lives

Foluso A. Fakorede, MD

Atherosclerosis and peripheral artery disease are significant long-term complications of diabetes that demand more education and quality care to prevent limb loss. The conclusion of National Diabetes Month offers an opportunity to draw attention to ways to prevent these outcomes and screen for them early.

Oral Semaglutide Shows Reduction in Cardiovascular Death, All-Cause Mortality in Type 2 Diabetes

November 24th 2018

Oral Semaglutide Shows Reduction in Cardiovascular Death, All-Cause Mortality in Type 2 Diabetes

Novo Nordisk plans to seek FDA approval for the GLP-1 receptor agonist in the first half of 2019.

November 19th 2018

Stricter Blood Pressure Guidelines Could Prevent Cardiovascular Events, but Debate Continues

A 2015 study sponsored by the National Institutes of Health made a change in blood pressure guidelines seem inevitable. But there is disagreement between the standards promoted by societies for family physicians and those for cardiologists, leading to confusion for those in daily practice.

This Week in Managed Care: November 16, 2018

November 16th 2018

This Week in Managed Care: November 16, 2018

This week, the top managed care news included research that showed cancer surpassed cardiovascular disease to be the leading cause of death in high-income counties; HHS Secretary Alex Azar announced a new mandatory payment model is coming to oncology; a policy change could make mental health treatment more available.

New Cholesterol Guidelines Call for Personalized Care

November 15th 2018

New Cholesterol Guidelines Call for Personalized Care

The guidelines unveiled at the American Heart Association annual meeting discuss when patients at the highest risk could be treated with a PCSK9 inhibitor.

Cancer Surpasses CVD as Leading Cause of Death in High-Income Counties

November 14th 2018

Cancer Surpasses CVD as Leading Cause of Death in High-Income Counties

Jaime Rosenberg

As a result of increased prevention and improved medical treatment of cardiovascular disease (CVD), and despite increasing rates of obesity and diabetes, cancer has gradually surpassed CVD as the leading cause of death in high-income counties. However, CVD is more likely to be the leading cause of death in low-income counties.

Gallup-Sharecare Report Shows How Diabetes Ranks Grew Across the US

November 13th 2018

Gallup-Sharecare Report Shows How Diabetes Ranks Grew Across the US

The report finds that another 1.7 million Americans have diabetes than would have been the case if rates had not increased.

This Week in Managed Care: November 9, 2018

November 9th 2018

This Week in Managed Care: November 9, 2018

This week, the top managed care stories included Medicaid expansion wins at the ballot box; new melanoma guidelines that promote recommended treatments and discuss genetic testing; research found high blood pressure in young adults predicts future cardiovascular events.

Low Health Literacy Linked to Early Death for Cardiovascular Patients

November 8th 2018

Low Health Literacy Linked to Early Death for Cardiovascular Patients

The study examined several social factors that can affect health outcomes when patients are hospitalized for cardiovascular events.

High Blood Pressure in Young Adults Indicative of CVD Events Later in Life

November 7th 2018

High Blood Pressure in Young Adults Indicative of CVD Events Later in Life

Jaime Rosenberg

Elevated blood pressure and stage 1 and 2 hypertension before age 40 puts young adults at higher risk for cardiovascular disease (CVD) events later in life compared to those with normal blood pressure, according to a new study published in JAMA.

Obesity Therapy Saxenda Gets Cardiovascular Safety Indication

November 1st 2018

Obesity Therapy Saxenda Gets Cardiovascular Safety Indication

The label change includes data from the LEADER trial, which showed that the same active ingredient, liraglutide, reduced major cardiovascular events when given at a lower dose.

October 29th 2018

Narrow Vote Calls for Keeping Drug Safety Trials, but Many See Changes

Cardiovascular outcomes trials have changed type 2 diabetes drug development and added to the knowledge base, but some think these giant studies make therapies too costly and discourage innovation.

Amgen Announces 60% Reduction in List Price of PCSK9 Inhibitor Evolocumab

October 25th 2018

Amgen Announces 60% Reduction in List Price of PCSK9 Inhibitor Evolocumab

Surabhi Dangi-Garimella, PhD

Amgen has announced that the price of its proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, evolocumab (Repatha), will be reduced by 60%, from an annual price of $14,100 down to $5850.

Analysis Estimates Empagliflozin Will Add Years to Life for People With Type 2 Diabetes

October 13th 2018

Analysis Estimates Empagliflozin Will Add Years to Life for People With Type 2 Diabetes

The analysis of data from EMPA-REG OUTCOME arrives as the FDA weighs the future of these large trials.

October 9th 2018

Joint Statement Released on Managing Hyperglycemia in Type 2 Diabetes

Patient preference should be considered because medications don't work if adherence is poor, the experts noted.

Horizon BCBSNJ Reports 10% Rise in Value-Based Payments

October 3rd 2018

Horizon BCBSNJ Reports 10% Rise in Value-Based Payments

For 2017, New Jersey's largest insurer made particularly good progress in certain diabetes measures and in cancer screenings.

Family History Linked With Early-Onset Atrial Fibrillation in Black and Latino Patients

September 25th 2018

Family History Linked With Early-Onset Atrial Fibrillation in Black and Latino Patients

Black and Latino individuals are less likely than their white peers to develop early-onset atrial fibrillation (EOAF), yet these individuals experience higher rates of stroke, heart failure, and mortality from AF than do white patients. To date, little has been known about this paradox, as most research into EOAF focuses on white patients.

September 24th 2018

MitraClip Reduces Hospital Stays, Deaths Among Patients With Heart Failure

Heart failure hospitalization has been a target for accountable care organizations seeking to find ways to cut costs from the healthcare system. But it remains to be seen how many of the estimated 2 million patients would gain access to the device if it received an expanded indication and payer coverage.

Diabetes Drug Farxiga Cuts Heart Risks in Topline Results

September 24th 2018

Diabetes Drug Farxiga Cuts Heart Risks in Topline Results

Full results from the cardiovascular outcomes trial for dapagliflozin (Farxiga) will be presented at the American Heart Association annual meeting in November.

...

5 6 7 8 9 10 11 12 13

...

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions